American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta. Abstract Number: 2912-74
Even though drug eluting stents have gained greatly in popularity for coronary intervention, hard evidence about the relative merits of paclitaxel as compared with sirolimus-eluting devices has been thin on the ground. At the ACC conference a meta analyis combined data from 5000 patients and showed superiority in terms of binary rates of restenosis (but not hard clinical endpoints) for the sirolumus eluting stent. Peter Goodwin heard the details from Antonio Abatte.